Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Neuro-Oncology
|
August 21, 2023
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics
Peter Kan, Visish M Srinivasan, Joy Gumin, et al.
Frontiers in Oncology
|
September 5, 2022
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells
Aram S Modrek, Eskil Eskilsson, Ravesanker Ezhilarasan, et al.
The Journal of Clinical Investigation
|
January 10, 2013
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
Brittany C Parker, Matti J Annala, David E Cogdell, et al.
Cancer Immunology Research
|
March 25, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome
Candice C Poon, Shelley M Herbrich, Yulong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models
Pascal O Zinn, Sanjay K Singh, Aikaterini Kotrotsou, et al.
Genes & Development
|
December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Krishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry
Teresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Neuro-Oncology
|
January 18, 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Mekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Neuro-Oncology
|
March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration
Xizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Neuro-Oncology
|
August 21, 2023
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics
Peter Kan, Visish M Srinivasan, Joy Gumin, et al.
Frontiers in Oncology
|
September 5, 2022
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells
Aram S Modrek, Eskil Eskilsson, Ravesanker Ezhilarasan, et al.
The Journal of Clinical Investigation
|
January 10, 2013
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
Brittany C Parker, Matti J Annala, David E Cogdell, et al.
Cancer Immunology Research
|
March 25, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome
Candice C Poon, Shelley M Herbrich, Yulong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models
Pascal O Zinn, Sanjay K Singh, Aikaterini Kotrotsou, et al.
Genes & Development
|
December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Krishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry
Teresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Neuro-Oncology
|
January 18, 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Mekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Neuro-Oncology
|
March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration
Xizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Page
of 7